Photo from Jeanne Tie/X
Jun 22, 2024, 11:50
Mark Gardner: The 5 year results from the DYNAMIC trial were shared at ASCO
Mark Gardner, SVP Genomic Medicine and Oncology at Quest Diagnostics, shared on LinkedIn:
“In case you missed it, the 5 year results from the DYNAMIC trial were shared at ASCO. The original findings held up, and the study further demonstrated that surviving ctDNA positive patients who received chemotherapy showed clearance in the blood after treatment. This implies MRD has value for both escalation and de-escalation of adjuvant therapy.”
Read further.
Source: Mark Gardner/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 14:06
Dec 21, 2024, 13:46
Dec 21, 2024, 13:40
Dec 21, 2024, 13:33